ALIM — Alimera Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- $174.86m
- $227.49m
- $80.75m
- 15
- 42
- 64
- 35
Annual cashflow statement for Alimera Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.4 | -5.34 | -4.37 | -18.1 | -20.1 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 3.38 | 1.83 | -0.692 | 2.62 | 12.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.181 | -1.39 | -1.35 | 2.69 | -15.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -4.15 | -2.19 | -3.22 | -9.97 | -14.3 |
| Capital Expenditures | -0.174 | -0.62 | -0.621 | -0.255 | -75.5 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.174 | -0.62 | -0.621 | -0.255 | -75.5 |
| Financing Cash Flow Items | -2.23 | -0.019 | 0 | -0.113 | -5.29 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.869 | 3.88 | 9.82 | -0.302 | 96.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.62 | 1.78 | 5.3 | -11.2 | 6.79 |